drugset / Trial / NCT03796364
Clinical Study of Endostatin in Improving Radiation Pneumonia and Fibrosis
RandomizedParallel-groupOpen-labelTreatment
Summary
To verify the efficacy and safety of endostatin in the treatment of SRILI(symptomatic radiation-induced lung injury) and fibrosis. The results of this study are expected to be a new clinical strategy for the treatment of radiation pneumonia and fibrosis.
Timeline
- Start
- 2018-09-01
- Primary completion
- 2020-05-31
- Completion
- 2020-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Endostar | Protein / enzyme biologic | — | Intravenous |